Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
Adi Jaffe, PhD, Co-Founder and Executive Director, Alternatives Behavioral Health, describes the benefits of the Soberlink sobriety monitoring device when treating patients with addiction. The Soberlink provides data…
Through embryonic stem cells and skin cells, scientists have successfully created human sperm and eggs, CBS News reports. A study published in the journal Cell describes scientists’ discovery of the…
David A. Fisher, MD, director, Total Joint Center, Indiana Orthopaedic Hospital discusses which patients qualify as candidates for total knee replacement surgery. According to Fisher, progressive loss of function that impacts…
Grant Campany, Senior Director, Qualcomm Tricorder XPRIZE, discusses the leading uses for wearable and ingestible medical sensors. According to Campany, these devices are particularly beneficial in monitoring body…
David A. Fisher, MD, director, Total Joint Center, Indiana Orthopaedic Hospital talks about the symptoms and treatments of osteoarthritis in the knee. Common symptoms include aching with activity,…
Merle Myerson, MD, EdD, FACC, FNLA, director, Mount Sinai Roosevelt and St Luke’s Cardiovascular Disease Prevention Program and Lipid Clinic discusses the response of triglycerides to lifestyle modifications…
Xavier Pi-Sunyer, MD, MPH and Steven Edelman, MD discuss the differences in A1C reduction when using GLP-1 receptor agonists versus DPP-4 inhibitors. GLP-1 receptor agonists have a larger reduction in A1C…
Heidi Hayes, MA, CEO, Donor Egg Bank USA, discusses an alternative solution for couples struggling with infertility who have been unsuccessful with traditional methods such as IUI and…
Xavier Pi-Sunyer, MD, MPH describes how physicians can make the decision between whether to prescribe an injectable GLP-1 agonist treatment or an oral DPP-4 inhibitor when seeking to lower…
Xavier Pi-Sunyer, MD, MPH, discusses incretin therapy, a treatment which increases insulin secretion in type 2 diabetes patients. According to Pi-Sunyer, GLP-1 can be raised in the blood…
